Genetic Testing for Global Developmental Delay in Early Childhood
JAMA Network Open · 2024
DOI: 10.1001/jamanetworkopen.2024.15084 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JAMA Network Open, 2024. Verfasst von Jiamei Zhang und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Medicine, Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Developmental Disabilities, Genetic Testing. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance Global developmental delay (GDD) is characterized by a complex etiology, diverse phenotypes, and high individual heterogeneity, presenting challenges for early clinical etiologic diagnosis. Cognitive impairment is the core symptom, and despite the pivotal role of genetic factors in GDD development, the understanding of them remains limited.
Objectives
To assess the utility of genetic detection in patients with GDD and to examine the potential molecular pathogenesis of GDD to identify targets for early intervention. Design, Setting, and Participants This multicenter, prospective cohort study enrolled patients aged 12 to 60 months with GDD from 6 centers in China from July 4, 2020, to August 31, 2023. Participants underwent trio whole exome sequencing (trio-WES) coupled with copy number variation sequencing (CNV-seq). Bioinformatics analysis was used to unravel pathogenesis and identify therapeutic targets. Main Outcomes and Measures The main outcomes of this study involved enhancing the rate of positive genetic diagnosis for GDD, broadening the scope of genetic testing indications, and investigating the underlying pathogenesis. The classification of children into levels of cognitive impairment was based on the developmental quotient assessed using the Gesell scale.
Results
The study encompassed 434 patients with GDD (262 [60%] male; mean [SD] age, 25.75 [13.24] months) with diverse degrees of cognitive impairment: mild (98 [23%]), moderate (141 [32%]), severe (122 [28%]), and profound (73 [17%]). The combined use of trio-WES and CNV-seq resulted in a 61% positive detection rate. Craniofacial abnormalities (odds ratio [OR], 2.27; 95% CI, 1.45-3.56), moderate or severe cognitive impairment (OR, 1.69; 95% CI, 1.05-2.70), and age between 12 and 24 months (OR, 1.57; 95% CI, 1.05-2.35) were associated with a higher risk of carrying genetic variants. Additionally, bioinformatics analysis suggested that genetic variants may induce alterations in brain development and function, which may give rise to cognitive impairment. Moreover, an association was found between the dopaminergic pathway and cognitive impairment. Conclusions and Relevance In this cohort study of patients with GDD, combining trio-WES with CNV-seq was a demonstrable, instrumental strategy for advancing the diagnosis of GDD. The close association among genetic variations, brain development, and clinical phenotypes contributed valuable insights into the pathogenesis of GDD. Notably, the dopaminergic pathway emerged as a promising focal point for potential targets in future precision medical interventions for GDD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Rehabilitation Medicine, Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Henan Key Laboratory of Child Brain Injury and Henan Pediatric Clinical Research Center, Institute of Neuroscience and Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Kunming Children's Hospital, Kunming, China.
- Department of Neurological Rehabilitation, Children's Hospital of Hebei Province, Shijiazhuang, China.
- Qinghai Provincial Women and Children's Hospital, Xining, China.
- Lanzhou University Second Hospital, Lanzhou, China.
Zitieren
APA
Zhang, J., Xu, Y., Liu, Y., Yue, L., Jin, H., Chen, Y., Wang, D., Wang, M., Chen, G., Yang, L., Zhang, G., Zhang, X., Li, S., Zhao, H., Zhao, Y., Niu, G., Gao, Y., Cai, Z., Yang, F., …, & Zhu, D. (2024). Genetic Testing for Global Developmental Delay in Early Childhood. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2024.15084
Vancouver
Zhang J, Xu Y, Liu Y, Yue L, Jin H, Chen Y, et al. Genetic Testing for Global Developmental Delay in Early Childhood. JAMA Network Open. 2024. doi:10.1001/jamanetworkopen.2024.15084
BibTeX
@article{Zhang2024,
author = {Zhang, Jiamei and Xu, Yiran and Liu, Yun and Yue, Ling and Jin, Hongfang and Chen, Yongqian and Wang, Dong and Wang, Mingmei and Chen, Gongxun and Yang, Lei and Zhang, Guangyu and Zhang, Xiaoli and Li, Sansong and Zhao, Huiling and Zhao, Yunxia and Niu, Guohui and Gao, Yongqiang and Cai, Zhijun and Yang, Fan and Zhu, Changlian and Zhu, Dengna},
title = {Genetic Testing for Global Developmental Delay in Early Childhood},
journal = {JAMA Network Open},
year = {2024},
doi = {10.1001/jamanetworkopen.2024.15084}
}
EUVIMED